Search - tctmd.com

Displaying 1 - 20 of 359

Sort: Relevancy | Date

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Conference News AHA 2025

Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia

Michael O'Riordan

November 14, 2025

News Daily News

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

Yael L. Maxwell

November 13, 2025

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

News Conference News ESC 2025

Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b

Caitlin E. Cox

August 31, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

Greater Frailty Means More Complications, Higher Mortality After PCI

Todd Neale

June 16, 2025

News Daily News

Dimitrios Karmpaliotis, Master Operator and Mentor With ‘Heart of Gold,’ Dies at 53

Yael L. Maxwell

June 09, 2025

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

News Daily News

Societies Push CV Trialists to Recruit More Women

L.A. McKeown

June 04, 2025

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Daily News

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Michael O'Riordan

March 06, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

Having Twins Ups the Risk of CVD Over the Next Year

Caitlin E. Cox

February 06, 2025

News Daily News

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Michael O'Riordan

February 05, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

Higher Lp(a) Indicates Greater Chance of Stenosis on CCTA in Patients With Chest Pain

Yael L. Maxwell

January 13, 2025

News Daily News

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Todd Neale

December 20, 2024

Advertisement

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Greater Frailty Means More Complications, Higher Mortality After PCI

Dimitrios Karmpaliotis, Master Operator and Mentor With ‘Heart of Gold,’ Dies at 53

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Societies Push CV Trialists to Recruit More Women

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

Having Twins Ups the Risk of CVD Over the Next Year

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Higher Lp(a) Indicates Greater Chance of Stenosis on CCTA in Patients With Chest Pain

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content